Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the PROMUS™ Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease.

Low-osmolar contrast media, such as GE Healthcare’s Omnipaque (Iohexol), make effective oral contrast agents for abdominal CT scans concluded a technical note written by a team of physicians

Gambro BCT, Inc., soon to be known as CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies

Integra LifeSciences announced the introduction of the Tibiaxys(TM) Plating System. The Tibiaxys(TM) Plating System has received clearance from the United States Food and Drug Administration (FDA)

CryoCath® Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, announced the introduction of Arctic Front® in Italy, Belgium and Spain

Geisinger Health System’s Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment.

Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, announced the availability of an online tool for hospitals to view automated medical supply dispensing performance data that quickly identifies opportunities to improve the efficiency of the supply chain.

GE Healthcare  IT , a unit of General Electric Company announced that Moses Cone Health System, a five hospital system based in North Carolina,  went live on the latest version 6.1  of GE’s Centricity® Enterprise Solution.

Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal coronary stent.  The device, the Global Therapeutics GTX® Coronary Stent System, is available immediately in the European Union and United Kingdom.

Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology.